Literature DB >> 9892952

Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis.

M A Gupta1, A K Gupta.   

Abstract

We examined the prevalence of depression (measured by the Carroll Rating Scale for Depression, CRSD), wishes to be dead and acute suicidal ideation among 480 patients with dermatological disorders that may be cosmetically disfiguring, i.e. non-cystic facial acne (n = 72; 5.6% suicidal ideation), alopecia areata (n = 45; 0% suicidal ideation), atopic dermatitis (n = 146; 2.1% suicidal ideation) and psoriasis (79 outpatients, 2.5% suicidal ideation and 138 inpatients, 7.2% suicidal ideation). Analysis of variance revealed that the severely affected psoriasis inpatients (mean +/- SD total body surface area affected: 52 +/- 23.4%) had the highest (P < 0.05) CRSD score, followed by the patients with mild to moderate acne; both scores were in the range for clinical depression (CRSD score > 10). The 5.6-7.2% prevalence of active suicidal ideation among the psoriasis and acne patients was higher than the 2.4-3.3% prevalence reported among general medical patients. Our findings highlight the importance of recognizing psychiatric comorbidity, especially depression, among dermatology patients and indicate that in some instances even clinically mild to moderate disease such as non-cystic facial acne can be associated with significant depression and suicidal ideation.

Entities:  

Mesh:

Year:  1998        PMID: 9892952     DOI: 10.1046/j.1365-2133.1998.02511.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  123 in total

Review 1.  [A decade of biologics in dermatology].

Authors:  G Wozel; M Meurer
Journal:  Hautarzt       Date:  2012-04       Impact factor: 0.751

2.  Biologics Provide Hope For Immune System Disorders: Patients tell the story and ask for appropriate access.

Authors:  Jill Marquardt
Journal:  Biotechnol Healthc       Date:  2007-10

3.  Association between Atopic Dermatitis and Depression in US Adults.

Authors:  Sherry H Yu; Jonathan I Silverberg
Journal:  J Invest Dermatol       Date:  2015-08-28       Impact factor: 8.551

4.  Management of acne: Canadian clinical practice guideline.

Authors:  Yuka Asai; Akerke Baibergenova; Maha Dutil; Shannon Humphrey; Peter Hull; Charles Lynde; Yves Poulin; Neil H Shear; Jerry Tan; John Toole; Catherine Zip
Journal:  CMAJ       Date:  2015-11-16       Impact factor: 8.262

Review 5.  Impact of psoriatic arthritis on the patient: through the lens of the WHO International Classification of Functioning, Health, and Disability.

Authors:  William J Taylor
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

6.  Condensation and validation of a 4-item index of the Acne-QoL.

Authors:  Jerry Tan; Karen Y Fung; Shahedul Khan
Journal:  Qual Life Res       Date:  2006-09-13       Impact factor: 4.147

7.  How psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center.

Authors:  Faranak Kamangar; Leah Isip; Tina Bhutani; Madison Dennis; Misha M Heller; Eric S Lee; Hong Nie; Wilson Liao
Journal:  J Dermatolog Treat       Date:  2011-11-10       Impact factor: 3.359

Review 8.  Isotretinoin, depression and suicide: a review of the evidence.

Authors:  Parker Magin; Dimity Pond; Wayne Smith
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

Review 9.  [Clinical variants of acne].

Authors:  T Jansen; S Grabbe; G Plewig
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

Review 10.  Psoriasis: advances in pathophysiology and management.

Authors:  A MacDonald; A D Burden
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.